Jennifer Bahr-Davidson

Jennifer Bahr-Davidson joined Lineage Cell Therapeutics as Director of Technical Operations & QA in December 2010. Jennifer brings over 25 years of experience in CMC and quality operations for cell and gene therapies, devices, small molecules, and diagnostics. Jennifer specializes in building quality and GMP operations teams and managing external resources to develop and manufacture investigational products. In her last position, Jennifer led various operational teams at Avigen for in-house development and production of clinical AAV vectors and external development and manufacture of oral small molecule investigational products. Prior to joining Avigen, Jennifer worked as an Associate Scientist, in Rare Reagent Manufacturing at Metra Biosystems, developing and producing antigens and antibodies utilized in ELISA-based clinical diagnostics kits. Jennifer obtained her BS in Chemical Engineering from the University of Colorado, Boulder, and her MS and Ph.D. in Chemical Engineering from Stanford University.